Creation of a recombinant rift valley fever virus with a two-segmented genome

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10310-10318

  Brennan, Benjamin ^a   Welch, Stephen R ^a   McLees, Angela ^a   Elliott, Richard M ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN; PROTEIN 78K; PROTEIN GC; PROTEIN GN; PROTEIN NSM; PROTEIN NSS; PROTEIN PRECURSOR; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC CODE; GENETIC STABILITY; INSECT CELL CULTURE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIFT VALLEY FEVER BUNYAVIRUS; TISSUE CULTURE; VIRION; VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINANT;

AEDES; ANIMALS; CELL LINE; GENETIC ENGINEERING; GENOME, VIRAL; GENOMIC INSTABILITY; MAMMALS; MOLECULAR BIOLOGY; RECOMBINATION, GENETIC; RIFT VALLEY FEVER VIRUS; VIRULENCE;

BUNYAVIRIDAE; HEXAPODA; MAMMALIA; RIFT VALLEY FEVER VIRUS;

EID: 80053947343     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05252-11     Document Type: Article

References (51)

1. Billecocq, A., et al. 2008. RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378:377-384.
2. Billecocq, A., et al. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78: 9798-9806.
3. Bird, B. H., et al. 2008. Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J. Virol. 82:2681-2691.
4. Bird, B. H., C. G. Albariño, and S. T. Nichol. 2007. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 362:10-15.
5. Bouloy, M., and R. Flick. 2009. Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res. 84:101-118.
6. Bouloy, M., et al. 2001. Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J. Virol. 75: 1371-1377.
7. Bouloy, M., and F. Weber. 2010. Molecular biology of Rift Valley fever virus. Open Virol. J. 4:8-14.
8. Bridgen, A., and R. M. Elliott. 1996. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl. Acad. Sci. U. S. A. 93:15400-15404.
9. Buchholz, U. J., S. Finke, and K. K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
10. Buchmeier, M., C. Peters, and J. de la Torre. 2007. Arenaviridae: the viruses and their replication, pp. 1792-1827. In D. Knipe and P. Howley (ed.), Fields virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Caplen, H., C. J. Peters, and D. H. Bishop. 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol. 66:2271-2277.
12. Elliott, R. M. 2009. Bunyaviruses and climate change. Clin. Microbiol. Infect. 15:510-517.
13. Emonet, S., L. Garidou, D. McGavern, and J. De La Torre. 2009. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc. Natl. Acad. Sci. U. S. A. 106:3473-3478.
14. Flick, K., et al. 2004. Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments. J. Virol. 78:11726-11738.
15. Gao, Q., E. W. Brydon, and P. Palese. 2008. A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J. Virol. 82:6419-6426.
16. Gao, Q., A. C. Lowen, T. T. Wang, and P. Palese. 2010. A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins. J. Virol. 84:8062-8071.
17. Gauliard, N., A. Billecocq, R. Flick, and M. Bouloy. 2006. Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351:170-179.
18. Gerrard, S. R., B. H. Bird, C. G. Albariño, and S. T. Nichol. 2007. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology 359:459-465.
19. Habjan, M., N. Penski, M. Spiegel, and F. Weber. 2008. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J. Gen. Virol. 89:2157-2166.
20. Habjan, M., et al. 2009. Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology 385:400-408.
21. Habjan, M., et al. 2009. NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase (PKR). J. Virol. 83:4365-4375.
22. Hai, R., A. Garcia-Sastre, D. E. Swayne, and P. Palese. 2011. A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains. J. Virol. 85:6832-6843.
23. Hutchinson, E. C., J. C. von Kirchbach, J. R. Gog, and P. Digard. 2010. Genome packaging in influenza A virus. J. Gen. Virol. 91:313-328.
24. Ikegami, T., and S. Makino. 2009. Rift Valley fever vaccines. Vaccine 27(Suppl. 4):D69-D72.
25. Ikegami, T., et al. 2009. Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E75-E85.
26. Ikegami, T., et al. 2009. Rift Valley fever virus NSs protein promotes posttranscriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog. 5:e1000287.
27. Ikegami, T., C. J. Peters, and S. Makino. 2005. Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J. Virol. 79:5606-5615.
28. Ikegami, T., S. Won, C. J. Peters, and S. Makino. 2007. Characterization of Rift Valley fever virus transcriptional terminations. J. Virol. 81:8421-8438.
29. Ikegami, T., S. Won, C. J. Peters, and S. Makino. 2006. Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 80:2933-2940.
30. Ikegami, T., S. Won, C. J. Peters, and S. Makino. 2005. Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J. Virol. 79:12106-12111.
31. Kascsak, R. J., and M. J. Lyons. 1978. Bunyamwera virus. II. The generation and nature of defective interfering particles. Virology 89:539-546.
32. Kohl, A. 2006. Genetic elements regulating packaging of the Bunyamwera orthobunyavirus genome. J. Gen. Virol. 87:177-187.
33. Lopez, N., R. Muller, C. Prehaud, and M. Bouloy. 1995. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J. Virol. 69:3972-3979.
34. Lowen, A. C., A. Boyd, J. K. Fazakerley, and R. M. Elliott. 2005. Attenuation of bunyavirus replication by rearrangement of viral coding and noncoding sequences. J. Virol. 79:6940-6946.
35. Masek, T., V. Vopalensky, P. Suchomelova, and M. Pospisek. 2005. Denaturing RNA electrophoresis in TAE agarose gels. Anal. Biochem. 336:46-50.
36. Muller, R., et al. 1995. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am. J. Trop. Med. Hyg. 53:405-411.
37. Obijeski, J. F., and F. A. Murphy. 1977. Bunyaviridae: recent biochemical developments. J. Gen. Virol. 37:1-14.
38. Overby, A. K., V. Popov, E. P. Neve, and R. F. Pettersson. 2006. Generation and analysis of infectious virus-like particles of Uukuniemi virus (Bunyaviridae): a useful system for studying bunyaviral packaging and budding. J. Virol. 80:10428-10435.
39. Overby, A. K., V. L. Popov, R. F. Pettersson, and E. P. Neve. 2007. The cytoplasmic tails of Uukuniemi virus (Bunyaviridae) G(N) and G(C) glycoproteins are important for intracellular targeting and the budding of viruslike particles. J. Virol. 81:11381-11391.
40. Piper, M. E., D. R. Sorenson, and S. R. Gerrard. 2011. Efficient cellular release of Rift Valley fever virus requires genomic RNA. PLoS One 6:e18070.
41. Sall, A. A., et al. 1999. Genetic reassortment of Rift Valley fever virus in nature. J. Virol. 73:8196-8200.
42. Shi, X., A. Kohl, P. Li, and R. M. Elliott. 2007. Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis. J. Virol. 81:10151-10160.
43. Shoemaker, T., et al. 2002. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg. Infect. Dis. 8:1415-1420.
44. Smithburn, K. C. 1949. Rift Valley fever: the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br. J. Exp. Pathol. 30:1-16.
45. Terasaki, K., S. Murakami, K. G. Lokugamage, and S. Makino. 2011. Mechanism of tripartite RNA genome packaging in Rift Valley fever virus. Proc. Natl. Acad. Sci. U. S. A. 108:804-809.
46. Turell, M. J., et al. 2008. Potential for North American mosquitoes to transmit Rift Valley fever virus. J. Am. Mosq. Control Assoc. 24:502-507.
47. Vialat, P., A. Billecocq, A. Kohl, and M. Bouloy. 2000. The S segment of Rift Valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J. Virol. 74:1538-1543.
48. Volkmer, N., M. C. Soares, and M. A. Rebello. 1983. Autointerference of Marituba Virus (Bunyaviridae) in mouse L cells by defective interfering particles. Intervirology 20:108-113.
49. Walker, J. S., R. C. Carter, F. Klein, S. E. Snowden, and R. E. Lincoln. 1969. Evaluation of factors related to growth of Rift Valley fever virus in suspended cell cultures. Appl. Microbiol. 17:658-664.
50. Won, S., T. Ikegami, C. J. Peters, and S. Makino. 2006. NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J. Virol. 80:8274-8278.
51. Won, S., T. Ikegami, C. J. Peters, and S. Makino. 2007. NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J. Virol. 81:13335-13345.